Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1431

1.

Developing the Core Pillars of Training Global Cardiovascular Health Researchers: Companionship, Light, and Fuel.

Yan LL, Vedanthan R, Mensah GA, Karmacharya B, Shrestha A, Fitzpatrick A, Duc HA, Tandon N, Davila-Roman VG, Huffman MD, Miranda JJ, Irazola V, Koju R, Newsome B, Yusuf S.

Glob Heart. 2019 Dec;14(4):387-389. doi: 10.1016/j.gheart.2019.08.005. No abstract available.

PMID:
31727269
2.

Reply to GASTRO-D-19-01953 and GASTRO-D-01789.

Moayyedi P, Eikelboom JW, Yusuf S.

Gastroenterology. 2019 Nov 5. pii: S0016-5085(19)41519-9. doi: 10.1053/j.gastro.2019.10.032. [Epub ahead of print] No abstract available.

PMID:
31704300
3.

Long-term follow-up of normal and structural heart ventricular tachycardia catheter ablation: real-world experience from a UK tertiary centre.

Adlan AM, Arujuna A, Dowd R, Hayat S, Panikker S, Foster W, Yusuf S, Umar F, Lellouche N, Osman F, Dhanjal T.

Open Heart. 2019 Sep 24;6(2):e000996. doi: 10.1136/openhrt-2018-000996. eCollection 2019.

4.

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.

Schmidt AF, Holmes MV, Preiss D, Swerdlow DI, Denaxas S, Fatemifar G, Faraway R, Finan C, Valentine D, Fairhurst-Hunter Z, Hartwig FP, Horta BL, Hypponen E, Power C, Moldovan M, van Iperen E, Hovingh K, Demuth I, Norman K, Steinhagen-Thiessen E, Demuth J, Bertram L, Lill CM, Coassin S, Willeit J, Kiechl S, Willeit K, Mason D, Wright J, Morris R, Wanamethee G, Whincup P, Ben-Shlomo Y, McLachlan S, Price JF, Kivimaki M, Welch C, Sanchez-Galvez A, Marques-Vidal P, Nicolaides A, Panayiotou AG, Onland-Moret NC, van der Schouw YT, Matullo G, Fiorito G, Guarrera S, Sacerdote C, Wareham NJ, Langenberg C, Scott RA, Luan J, Bobak M, Malyutina S, Pająk A, Kubinova R, Tamosiunas A, Pikhart H, Grarup N, Pedersen O, Hansen T, Linneberg A, Jess T, Cooper J, Humphries SE, Brilliant M, Kitchner T, Hakonarson H, Carrell DS, McCarty CA, Lester KH, Larson EB, Crosslin DR, de Andrade M, Roden DM, Denny JC, Carty C, Hancock S, Attia J, Holliday E, Scott R, Schofield P, O'Donnell M, Yusuf S, Chong M, Pare G, van der Harst P, Said MA, Eppinga RN, Verweij N, Snieder H; Lifelines Cohort authors, Christen T, Mook-Kanamori DO; ICBP Consortium, Gustafsson S, Lind L, Ingelsson E, Pazoki R, Franco O, Hofman A, Uitterlinden A, Dehghan A, Teumer A, Baumeister S, Dörr M, Lerch MM, Völker U, Völzke H, Ward J, Pell JP, Meade T, Christophersen IE, Maitland-van der Zee AH, Baranova EV, Young R, Ford I, Campbell A, Padmanabhan S, Bots ML, Grobbee DE, Froguel P, Thuillier D, Roussel R, Bonnefond A, Cariou B, Smart M, Bao Y, Kumari M, Mahajan A, Hopewell JC, Seshadri S; METASTROKE Consortium of the ISGC, Dale C, Costa RPE, Ridker PM, Chasman DI, Reiner AP, Ritchie MD, Lange LA, Cornish AJ, Dobbins SE, Hemminki K, Kinnersley B, Sanson M, Labreche K, Simon M, Bondy M, Law P, Speedy H, Allan J, Li N, Went M, Weinhold N, Morgan G, Sonneveld P, Nilsson B, Goldschmidt H, Sud A, Engert A, Hansson M, Hemingway H, Asselbergs FW, Patel RS, Keating BJ, Sattar N, Houlston R, Casas JP, Hingorani AD.

BMC Cardiovasc Disord. 2019 Oct 29;19(1):240. doi: 10.1186/s12872-019-1187-z.

5.

CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas.

Mcaddy NC, Hallin M, Strauss D, Smith M, Hayes A, Yusuf S, Moskovic E, Fotiadis N, van Houdt W, Jones RL, Gronchi A, Thway K, Messiou C.

Eur J Surg Oncol. 2019 Oct 10. pii: S0748-7983(19)30888-1. doi: 10.1016/j.ejso.2019.10.007. [Epub ahead of print]

PMID:
31653457
6.

Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.

Vanassche T, Verhamme P, Anand SS, Shestakovska O, Fox KA, Bhatt DL, Avezum A, Alings M, Aboyans V, Maggioni AP, Widimsky P, Berkowitz SD, Yusuf S, Connolly SJ, Eikelboom JW, Bosch J.

Eur J Prev Cardiol. 2019 Oct 15:2047487319882154. doi: 10.1177/2047487319882154. [Epub ahead of print]

PMID:
31615291
7.

Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy.

Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC.

J Cardiovasc Imaging. 2019 Oct;27(4):268-279. doi: 10.4250/jcvi.2019.27.e38.

8.

Enhanced ventricular tachycardia substrate resolution with a novel omnipolar high-density mapping catheter: the omnimapping study.

Proietti R, Adlan AM, Dowd R, Assadullah S, Aldhoon B, Panikker S, Foster W, Yusuf S, Hayat S, Osman F, Banerjee P, Dhanjal T.

J Interv Card Electrophysiol. 2019 Oct 9. doi: 10.1007/s10840-019-00625-9. [Epub ahead of print]

PMID:
31598876
9.

Cardiotoxicity Related to Radiation Therapy.

Shoukat S, Zheng D, Yusuf SW.

Cardiol Clin. 2019 Nov;37(4):449-458. doi: 10.1016/j.ccl.2019.07.010. Review.

PMID:
31587786
10.

My Journey, the AAP, and PIR.

Yusuf S.

Pediatr Rev. 2019 Oct;40(Suppl 1):39. doi: 10.1542/pir.2019-40S39. Epub 2019 Oct 1. No abstract available.

PMID:
31575697
11.

The Current State of Pediatric Health Care: Changes and Challenges.

Yusuf S, Garfunkel L, Forster C, Serwint JR.

Pediatr Rev. 2019 Oct;40(Suppl 1):8-9. doi: 10.1542/pir.2019-40S08. No abstract available.

PMID:
31575684
12.

Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease.

Anand SS, Tu JV, Desai D, Awadalla P, Robson P, Jacquemont S, Dummer T, Le N, Parker L, Poirier P, Teo K, Lear SA, Yusuf S, Tardif JC, Marcotte F, Busseuil D, Després JP, Black SE, Kirpalani A, Parraga G, Noseworthy MD, Dick A, Leipsic J, Kelton D, Vena J, Thomas M, Schulze KM, Larose E, Moody AR, Smith EE, Friedrich MG; Canadian Alliance for Healthy Hearts and Minds Cohort .

Eur Heart J Cardiovasc Imaging. 2019 Sep 30. pii: jez226. doi: 10.1093/ehjci/jez226. [Epub ahead of print]

PMID:
31565735
13.

68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours.

Sharma R, Wang WM, Yusuf S, Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD.

Radiother Oncol. 2019 Sep 18. pii: S0167-8140(19)33076-2. doi: 10.1016/j.radonc.2019.09.003. [Epub ahead of print]

PMID:
31542317
14.

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.

Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C, Berkowitz SD, Cook Bruns N, Muehlhofer E, Diaz R, Maggioni AP, Yusuf S.

J Am Coll Cardiol. 2019 Sep 24;74(12):1519-1528. doi: 10.1016/j.jacc.2019.07.065.

15.

Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.

Perera KS, Ng KKH, Nayar S, Catanese L, Dyal L, Sharma M, Connolly SJ, Yusuf S, Bosch J, Eikelboom JW, Hart RG.

JAMA Neurol. 2019 Sep 16. doi: 10.1001/jamaneurol.2019.2984. [Epub ahead of print]

PMID:
31524941
16.

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook-Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S.

Circulation. 2019 Oct 29;140(18):1451-1459. doi: 10.1161/CIRCULATIONAHA.119.041949. Epub 2019 Sep 12.

PMID:
31510769
17.

Graphical comparisons of relative disease burden across multiple risk factors.

Ferguson J, O'Leary N, Maturo F, Yusuf S, O'Donnell M.

BMC Med Res Methodol. 2019 Sep 11;19(1):186. doi: 10.1186/s12874-019-0827-4.

18.

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G.

Lancet. 2019 Sep 3. pii: S0140-6736(19)32008-2. doi: 10.1016/S0140-6736(19)32008-2. [Epub ahead of print] Erratum in: Lancet. 2019 Oct 7;:.

PMID:
31492503
19.

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.

Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, Diaz R, Avezum A, Oliveira GBF, Wielgosz A, Parambath SR, Mony P, Alhabib KF, Temizhan A, Ismail N, Chifamba J, Yeates K, Khatib R, Rahman O, Zatonska K, Kazmi K, Wei L, Zhu J, Rosengren A, Vijayakumar K, Kaur M, Mohan V, Yusufali A, Kelishadi R, Teo KK, Joseph P, Yusuf S.

Lancet. 2019 Sep 3. pii: S0140-6736(19)32007-0. doi: 10.1016/S0140-6736(19)32007-0. [Epub ahead of print] Erratum in: Lancet. 2019 Sep 6;:.

PMID:
31492501
20.

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.

Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S.

Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2.

PMID:
31488369
21.

The Effect of Steroids in Patients Undergoing Cardiopulmonary Bypass: An Individual Patient Meta-Analysis of Two Randomized Trials.

Whitlock RP, Dieleman JM, Belley-Cote E, Vincent J, Zhang M, Devereaux PJ, Kalkman CJ, van Dijk D, Yusuf S.

J Cardiothorac Vasc Anesth. 2019 Jun 20. pii: S1053-0770(19)30565-8. doi: 10.1053/j.jvca.2019.06.012. [Epub ahead of print]

PMID:
31401207
22.

Access to Essential Medicines for Circulatory Diseases: A Call to Action.

McKee M, Scarlatescu O, Wood D, Eiselé JL, Perel P, Yusuf S.

Glob Heart. 2019 Dec;14(4):399-400. doi: 10.1016/j.gheart.2019.07.008. Epub 2019 Aug 2. No abstract available.

PMID:
31383576
23.

Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial.

Joshi R, Agrawal T, Fathima F, Usha T, Thomas T, Misquith D, Kalantri S, Chidambaram N, Raj T, Singamani A, Hegde S, Xavier D, Devereaux PJ, Pais P, Gupta R, Yusuf S.

Am Heart J. 2019 Oct;216:9-19. doi: 10.1016/j.ahj.2019.06.007. Epub 2019 Jun 19.

PMID:
31377568
24.

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).

Leong DP, McMurray JJV, Joseph PG, Yusuf S.

J Am Coll Cardiol. 2019 Aug 6;74(5):683-698. doi: 10.1016/j.jacc.2019.04.068. Review.

PMID:
31370961
25.

The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).

Joseph P, Swedberg K, Leong DP, Yusuf S.

J Am Coll Cardiol. 2019 Aug 6;74(5):672-682. doi: 10.1016/j.jacc.2019.04.067. Review.

PMID:
31370960
26.

Keeping Kids Safe in and Around the Water: New AAP Guidelines.

McCallin T, Yusuf S.

Tex Med. 2019 Jul 1;115(7):6-7.

PMID:
31334819
27.

Isolated Bilateral Pinna Swelling: A Rare Initial Presentation of Leprosy.

Yusuf SYM, Ismail IA, Hamid RA, Jamil NA, Yasin MM.

Open Access Maced J Med Sci. 2019 Jun 15;7(11):1815-1817. doi: 10.3889/oamjms.2019.481. eCollection 2019 Jun 15.

28.

Development and evaluation educational videos of diabetic foot care in traditional languages to enhance knowledge of patients diagnosed with diabetes and risk for diabetic foot ulcers.

Abrar EA, Yusuf S, Sjattar EL, Rachmawaty R.

Prim Care Diabetes. 2019 Jul 13. pii: S1751-9918(19)30001-4. doi: 10.1016/j.pcd.2019.06.005. [Epub ahead of print]

PMID:
31311727
29.

Associations of cardiometabolic outcomes with indices of obesity in children aged 5 years and younger.

Teo KK, Rafiq T, Anand SS, Schulze KM, Yusuf S, McDonald SD, Wahi G, Abdalla N, Desai D, Atkinson SA, Morrison KM.

PLoS One. 2019 Jul 5;14(7):e0218816. doi: 10.1371/journal.pone.0218816. eCollection 2019.

30.

Jotec E-Ventus BX Stent Graft Deployment in the FEVAR and Iliac Branch Device: Single Centre Experience.

Sayed T, Ahmed I, Rodway A, El Sakka K, Yusuf SW.

Ann Vasc Dis. 2019 Jun 25;12(2):171-175. doi: 10.3400/avd.oa.18-00101.

31.

Exploratory qualitative study to understand the underlying motivations and strategies of the private for-profit healthcare sector in urban Bangladesh.

Adams AM, Ahmed R, Shuvo TA, Yusuf SS, Akhter S, Anwar I.

BMJ Open. 2019 Jul 3;9(7):e026586. doi: 10.1136/bmjopen-2018-026586.

32.

Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.

Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C.

Eur Radiol. 2019 Jul 2. doi: 10.1007/s00330-019-06281-x. [Epub ahead of print]

PMID:
31267214
33.

Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.

Anand SS, Eikelboom JW, Dyal L, Bosch J, Neumann C, Widimsky P, Avezum AA, Probstfield J, Cook Bruns N, Fox KAA, Bhatt DL, Connolly SJ, Yusuf S; COMPASS Trial Investigators.

J Am Coll Cardiol. 2019 Jul 2;73(25):3271-3280. doi: 10.1016/j.jacc.2019.02.079.

34.

Multimodality imaging in carcinoid heart disease.

Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, Kim PY, Palaskas NL, Yusuf S, Gladish G, Hassan S.

Open Heart. 2019 Jun 4;6(1):e001060. doi: 10.1136/openhrt-2019-001060. eCollection 2019. Review.

35.

Safety of Transesophageal Echocardiography in Patients with Thrombocytopenia.

Kitkungvan D, Kalluru D, Lunagariya A, Sanchez L, Yusuf SW, Hassan S, Palaskas N, Mouhayar E, Banchs J.

J Am Soc Echocardiogr. 2019 Aug;32(8):1010-1015. doi: 10.1016/j.echo.2019.04.421. Epub 2019 Jun 22.

PMID:
31239084
36.

Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.

Conen D, Alonso-Coello P, Douketis J, Chan MTV, Kurz A, Sigamani A, Parlow JL, Wang CY, Villar JC, Srinathan SK, Tiboni M, Malaga G, Guyatt G, Sivakumaran S, Rodriguez Funes MV, Cruz P, Yang H, Dresser GK, Alvarez-Garcia J, Schricker T, Jones PM, Drummond LW, Balasubramanian K, Yusuf S, Devereaux PJ.

Eur Heart J. 2019 Jun 25. pii: ehz431. doi: 10.1093/eurheartj/ehz431. [Epub ahead of print]

PMID:
31237939
37.

Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk.

Pigeyre M, Sjaarda J, Mao S, Chong M, Hess S, Yusuf S, Gerstein H, Paré G.

Diabetes Care. 2019 Sep;42(9):1800-1808. doi: 10.2337/dc18-2444. Epub 2019 Jun 24.

PMID:
31235487
38.

Letter by Mente et al Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease".

Mente A, O'Donnell MJ, Yusuf S.

Hypertension. 2019 Aug;74(2):e26. doi: 10.1161/HYPERTENSIONAHA.119.13321. Epub 2019 Jun 24. No abstract available.

PMID:
31230541
39.

Digoxin-mortality: randomized vs. observational comparison in the DIG trial.

Aguirre Dávila L, Weber K, Bavendiek U, Bauersachs J, Wittes J, Yusuf S, Koch A.

Eur Heart J. 2019 Oct 21;40(40):3336-3341. doi: 10.1093/eurheartj/ehz395.

40.

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.

Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S.

Circulation. 2019 Aug 13;140(7):529-537. doi: 10.1161/CIRCULATIONAHA.119.039609. Epub 2019 Jun 5.

41.

Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S; AFGen Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; INVENT Consortium; STARNET, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Björkegren JLM, Codoni V, Civelek M, Smith NL, Trégouët DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD; BioBank Japan Cooperative Hospital Group; COMPASS Consortium; EPIC-CVD Consortium; EPIC-InterAct Consortium; International Stroke Genetics Consortium (ISGC); METASTROKE Consortium; Neurology Working Group of the CHARGE Consortium; NINDS Stroke Genetics Network (SiGN); UK Young Lacunar DNA Study; MEGASTROKE Consortium, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M.

Nat Genet. 2019 Jul;51(7):1192-1193. doi: 10.1038/s41588-019-0449-0.

42.

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.

PMID:
31152740
43.

Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent.

Cairns JA, Eikelboom JW, Shestakovska O, Yusuf S, DeMets D.

J Am Coll Cardiol. 2019 Jun 4;73(21):2769-2772. doi: 10.1016/j.jacc.2019.03.479. No abstract available.

PMID:
31146821
44.

Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial.

Fox KAA, Eikelboom JW, Shestakovska O, Connolly SJ, Metsarinne KP, Yusuf S.

J Am Coll Cardiol. 2019 May 14;73(18):2243-2250. doi: 10.1016/j.jacc.2019.02.048.

45.

Health Effects of Household Solid Fuel Use: Findings from 11 Countries within the Prospective Urban and Rural Epidemiology Study.

Hystad P, Duong M, Brauer M, Larkin A, Arku R, Kurmi OP, Fan WQ, Avezum A, Azam I, Chifamba J, Dans A, du Plessis JL, Gupta R, Kumar R, Lanas F, Liu Z, Lu Y, Lopez-Jaramillo P, Mony P, Mohan V, Mohan D, Nair S, Puoane T, Rahman O, Lap AT, Wang Y, Wei L, Yeates K, Rangarajan S, Teo K, Yusuf S; [on behalf of Prospective Urban and Rural Epidemiological (PURE) Study investigators].

Environ Health Perspect. 2019 May;127(5):57003. doi: 10.1289/EHP3915.

46.

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Cook Bruns N, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko AN, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Aug;157(2):403-412.e5. doi: 10.1053/j.gastro.2019.04.041. Epub 2019 May 2.

PMID:
31054846
47.

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients.

Khunti K, Jung H, Dans AL, Held C, Dagenais GR, Yusuf S, Lonn E.

Can J Cardiol. 2019 May;35(5):644-652. doi: 10.1016/j.cjca.2019.03.002. Epub 2019 Mar 19.

PMID:
31030865
48.

Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.

Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, Kaur M, Khatib R, Kruger IM, Lamelas P, Lanas F, Lear SA, Li W, Wang C, Quiang D, Wang Y, Lopez-Jaramillo P, Mohammadifard N, Mohan V, Mony PK, Poirier P, Srilatha S, Szuba A, Teo K, Wielgosz A, Yeates KE, Yusoff K, Yusuf R, Yusufali AH, Attaei MW, McKee M, Yusuf S.

Lancet Glob Health. 2019 Jun;7(6):e748-e760. doi: 10.1016/S2214-109X(19)30045-2. Epub 2019 Apr 23.

49.

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.

Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.

Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.

50.

Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries.

Lamelas P, Diaz R, Orlandini A, Avezum A, Oliveira G, Mattos A, Lanas F, Seron P, Oliveros MJ, Lopez-Jaramillo P, Otero J, Camacho P, Miranda J, Bernabe-Ortiz A, Malaga G, Irazola V, Gutierrez L, Rubinstein A, Castellana N, Rangarajan S, Yusuf S.

J Hypertens. 2019 Sep;37(9):1813-1821. doi: 10.1097/HJH.0000000000002108.

PMID:
30964825

Supplemental Content

Support Center